Protein Symbol | Approved Name | Docking Scores |
Similarity Score |
Best Match | ||
---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | ||||
5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -10.43 | -10.46 | -9.26 | 38.35% | CHEMBL321562 |
5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -9.54 | -9.42 | N/A | 47.37% | CHEMBL941 |
5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -10.02 | -9.78 | -9.92 | 49.12% | CHEMBL1829959 |
5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -9.08 | -9.07 | N/A | 39.80% | CHEMBL115769 |
AA1R_HUMAN | adenosine A1 receptor | -9.49 | -9.17 | -7.53 | 57.83% | CHEMBL1650173 |
AA2AR_HUMAN | adenosine A2a receptor | -9.09 | -9.30 | -10.35 | 55.13% | CHEMBL406714 |
ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -9.89 | -10.73 | -10.10 | 48.56% | CHEMBL1085028 |
ACE_HUMAN | angiotensin I converting enzyme | -8.87 | -8.80 | -5.81 | 30.43% | CHEMBL1242210 |
ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -7.15 | N/A | N/A | 19.60% | CHEMBL386114 |
ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -5.06 | -7.99 | -4.02 | N/A | N/A |
ACM1_HUMAN | cholinergic receptor muscarinic 1 | -8.32 | 1.06 | N/A | 36.11% | CHEMBL3747781 |
ACM4_HUMAN | cholinergic receptor muscarinic 4 | -8.49 | -7.50 | N/A | 33.50% | CHEMBL296419 |
ADRB2_HUMAN | adrenoceptor beta 2 | -8.60 | -8.67 | -9.94 | 43.75% | CHEMBL1406272 |
AGTR2_HUMAN | angiotensin II receptor type 2 | -9.09 | -9.16 | -9.01 | 37.04% | CHEMBL2435824 |
ALDR_HUMAN | aldo-keto reductase family 1 member B | -9.01 | -9.56 | -8.41 | 29.02% | CHEMBL1169757 |
AMPN_HUMAN | alanyl aminopeptidase, membrane | -9.20 | -9.61 | -9.36 | 28.40% | CHEMBL1798007 |
AOFA_HUMAN | monoamine oxidase A | -9.64 | -8.67 | -9.16 | 42.08% | CHEMBL1258955 |
AOFB_HUMAN | monoamine oxidase B | -10.14 | -6.86 | -9.30 | 37.97% | CHEMBL2408565 |
BACE1_HUMAN | beta-secretase 1 | -7.70 | -8.64 | -9.14 | 41.86% | CHEMBL1241481 |
CAH2_HUMAN | carbonic anhydrase 2 | -7.79 | -8.76 | -9.09 | 47.37% | CHEMBL941 |
CASP1_HUMAN | caspase 1 | -7.14 | -8.97 | -7.13 | 38.83% | CHEMBL202025 |
CDK5_HUMAN | cyclin dependent kinase 5 | -8.88 | -9.15 | -7.55 | 85.89% | CHEMBL1190711 |
CHLE_HUMAN | butyrylcholinesterase | -10.11 | -9.62 | -9.83 | 34.10% | CHEMBL219262 |
CNR1_HUMAN | cannabinoid receptor 1 | -7.88 | -9.52 | -10.12 | 41.99% | CHEMBL4105029 |
CNR2_HUMAN | cannabinoid receptor 2 | -10.23 | -9.82 | N/A | 44.32% | CHEMBL387654 |
COLI_HUMAN | proopiomelanocortin | -9.55 | -8.85 | -9.54 | N/A | N/A |
COMT_HUMAN | catechol-O-methyltransferase | -6.65 | -6.45 | -6.96 | 30.57% | CHEMBL3798524 |
CRP_HUMAN | C-reactive protein | -6.81 | -7.12 | N/A | N/A | N/A |
CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | 1.51 | N/A | N/A | 33.15% | CHEMBL3609011 |
CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -9.14 | -8.14 | -8.59 | 32.68% | CHEMBL1802329 |
DRD2_HUMAN | dopamine receptor D2 | -9.22 | N/A | N/A | 41.67% | CHEMBL231078 |
DRD3_HUMAN | dopamine receptor D3 | -8.82 | N/A | N/A | 41.67% | CHEMBL231078 |
DRD4_HUMAN | dopamine receptor D4 | -9.66 | -9.81 | N/A | 41.58% | CHEMBL563109 |
EDN1_HUMAN | endothelin 1 | -8.61 | N/A | N/A | N/A | N/A |
ESR1_HUMAN | estrogen receptor 1 | -7.80 | -9.42 | -8.44 | 40.78% | CHEMBL59184 |
FABP5_HUMAN | fatty acid binding protein 5 | -10.16 | -6.28 | -6.32 | 38.58% | CHEMBL3941588 |
FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -9.95 | N/A | N/A | 50.54% | CHEMBL1241473 |
GLRA3_HUMAN | glycine receptor alpha 3 | -9.18 | -9.29 | -9.18 | 23.88% | CHEMBL4070615 |
GLRA3_HUMAN | glycine receptor alpha 3 | -9.50 | N/A | N/A | 23.88% | CHEMBL4070615 |
GRM5_HUMAN | glutamate metabotropic receptor 5 | -6.95 | -10.35 | -9.94 | 42.55% | CHEMBL2408571 |
HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -8.37 | -7.71 | -8.24 | 36.68% | CHEMBL264951 |
HRH1_HUMAN | histamine receptor H1 | -7.94 | N/A | N/A | 40.38% | CHEMBL3752885 |
HYES_HUMAN | epoxide hydrolase 2 | -8.66 | -9.49 | -8.55 | 46.19% | CHEMBL2336313 |
IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -9.80 | N/A | N/A | 58.86% | CHEMBL1082511 |
MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -8.71 | -9.17 | N/A | 46.08% | CHEMBL2135037 |
MIF_HUMAN | macrophage migration inhibitory factor | -7.04 | -9.10 | -6.30 | 29.54% | CHEMBL3917143 |
MK01_HUMAN | mitogen-activated protein kinase 1 | -9.61 | -8.68 | -8.19 | 85.89% | CHEMBL1190711 |
MK03_HUMAN | mitogen-activated protein kinase 3 | -8.55 | -9.41 | -8.52 | 38.64% | CHEMBL3544964 |
MTOR_HUMAN | mechanistic target of rapamycin kinase | -9.45 | -9.76 | -9.51 | 57.06% | CHEMBL565428 |
NEP_HUMAN | membrane metalloendopeptidase | -8.84 | -7.90 | -9.04 | 35.27% | CHEMBL34369 |
NK1R_HUMAN | tachykinin receptor 1 | -8.90 | -9.03 | -9.11 | 41.00% | CHEMBL205829 |
NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -8.18 | -8.38 | -8.40 | 20.90% | CHEMBL2333945 |
NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -9.18 | -10.19 | -10.40 | 32.96% | CHEMBL217904 |
NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -9.02 | -8.28 | -8.40 | 30.08% | CHEMBL162577 |
NOS1_HUMAN | nitric oxide synthase 1 | -9.30 | -9.17 | -9.07 | 39.56% | CHEMBL185247 |
NOS2_HUMAN | nitric oxide synthase 2 | -8.51 | -8.86 | -6.76 | 43.91% | CHEMBL220064 |
NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -9.94 | -9.77 | -9.39 | 53.75% | CHEMBL2004515 |
OPRD_HUMAN | opioid receptor delta 1 | -8.02 | -7.63 | -7.76 | 38.46% | CHEMBL212368 |
OPRK_HUMAN | opioid receptor kappa 1 | -10.24 | -9.47 | -9.52 | 35.61% | CHEMBL1784685 |
OPRM_MOUSE | Mu-type opioid receptor | -9.67 | -8.15 | N/A | 35.78% | CHEMBL605510 |
OPRX_HUMAN | opioid related nociceptin receptor 1 | -7.95 | -8.08 | -8.72 | 35.61% | CHEMBL1784685 |
P2RX3_HUMAN | purinergic receptor P2X 3 | -6.73 | -6.67 | -6.92 | 40.83% | CHEMBL3091627 |
P2Y12_HUMAN | purinergic receptor P2Y12 | -8.34 | -7.67 | -9.49 | 36.09% | CHEMBL3322631 |
PAR1_HUMAN | coagulation factor II thrombin receptor | -8.13 | N/A | N/A | 31.70% | CHEMBL110998 |
PDE4B_HUMAN | phosphodiesterase 4B | -8.83 | -9.54 | -10.21 | 46.74% | CHEMBL1782296 |
PDE5A_HUMAN | phosphodiesterase 5A | -10.01 | -9.72 | -9.18 | 42.86% | CHEMBL541845 |
PERM_HUMAN | myeloperoxidase | -9.10 | -8.99 | -8.55 | 37.95% | CHEMBL581893 |
PGH1_SHEEP | Prostaglandin G/H synthase 1 | -7.75 | -8.70 | -8.95 | 35.24% | CHEMBL368682 |
PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | -7.04 | -7.19 | -7.38 | 44.89% | CHEMBL561950 |
PPAP_HUMAN | acid phosphatase 3 | -8.45 | N/A | N/A | 19.35% | CHEMBL507996 |
PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -9.80 | -9.59 | -10.00 | 44.04% | CHEMBL4078107 |
PRGR_HUMAN | progesterone receptor | 0.35 | 2.79 | -8.24 | 35.50% | CHEMBL3337731 |
PTGES_HUMAN | prostaglandin E synthase | -7.48 | N/A | N/A | 44.69% | CHEMBL2336518 |
SC6A4_HUMAN | solute carrier family 6 member 4 | -9.95 | -10.12 | -9.81 | 47.37% | CHEMBL941 |
SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -8.62 | N/A | N/A | 51.55% | CHEMBL3983452 |
TLR4_HUMAN | toll like receptor 4 | -8.00 | -8.12 | -8.54 | 27.67% | CHEMBL1824677 |
TNFA_HUMAN | tumor necrosis factor | -8.38 | N/A | N/A | 33.33% | CHEMBL110421 |
TRBM_HUMAN | thrombomodulin | -8.23 | -7.98 | N/A | N/A | N/A |
TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -8.75 | -7.49 | N/A | N/A | N/A |
TRPM8_FICAL | Uncharacterized protein | -9.63 | N/A | N/A | N/A | N/A |
TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -8.90 | N/A | N/A | 49.44% | CHEMBL227364 |
TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -8.19 | -8.26 | N/A | N/A | N/A |
TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -7.46 | -7.60 | N/A | 32.00% | CHEMBL3696471 |
TRXR1_HUMAN | thioredoxin reductase 1 | -9.33 | -10.17 | -7.12 | N/A | N/A |
TRY1_HUMAN | serine protease 1 | -6.83 | N/A | N/A | 37.58% | CHEMBL104505 |